|
7 Companies |
|
7 Products |
|
7 Products |
|
22 Mechanisms of Action |
|
1 Trial |
|
107 News |
|
| 123» |
- | Trial completion: Photodynamic Therapy in Treating Patients With Premalignant or Early Stage Head and Neck Tumors (clinicaltrials.gov) - Apr 23, 2019
P1, N=35, Completed, Sponsor: Abramson Cancer Center of the University of Pennsylvania
Active, not recruiting --> Completed
- | Biomarker, Enrollment change, Trial withdrawal: Biomarkers in Tissue Samples From Patients Who Have Undergone Neck Dissection for Oral Cancer (clinicaltrials.gov) - Jan 30, 2019
P=N/A, N=0, Withdrawn, Sponsor: Alliance for Clinical Trials in Oncology
Active, not recruiting --> Completed N=161 --> 0 | Recruiting --> Withdrawn
- | Trial completion, Phase classification, Enrollment change: Trial of IIb Preserving Neck Dissection (clinicaltrials.gov) - Jul 17, 2018
P=N/A, N=32, Completed, Sponsor: Banaras Hindu University
N=161 --> 0 | Recruiting --> Withdrawn Recruiting --> Completed | Phase classification: P3 --> PN/A | N=100 --> 32
- | Trial completion: Fluorescent Visualization in Early Oral Cancer (clinicaltrials.gov) - May 2, 2018
P=N/A, N=40, Completed, Sponsor: University of Calgary
Recruiting --> Completed | Phase classification: P3 --> PN/A | N=100 --> 32 Active, not recruiting --> Completed
- | celecoxib oral / Generic mfg.
Biomarker, Trial completion, IO biomarker: Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia (clinicaltrials.gov) - Mar 30, 2018
P2, N=23, Completed, Sponsor: Dana-Farber Cancer Institute
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion date, Trial primary completion date: Acupuncture in Treating Dry Mouth Caused By Radiation Therapy in Patients With Head and Neck Cancer (clinicaltrials.gov) - Feb 14, 2018
P3, N=240, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed Trial primary completion date: Nov 2018 --> Nov 2019 | Trial completion date: Nov 2018 --> Nov 2020
- | Trial completion, Enrollment change, Trial primary completion date: Spectroscopy for Diagnostic Assessment of Oral Mucosal Lesions (clinicaltrials.gov) - Jan 19, 2018
P=N/A, N=381, Completed, Sponsor: M.D. Anderson Cancer Center
Trial primary completion date: Nov 2018 --> Nov 2019 | Trial completion date: Nov 2018 --> Nov 2020 Active, not recruiting --> Completed | N=259 --> 381 | Trial primary completion date: Jul 2018 --> Jan 2018
- | Biomarker, Trial completion, Enrollment change, Epigenetic controller: Validation of DNA Methylation Biomarkers for Oral Cancer Detection (clinicaltrials.gov) - Dec 26, 2017
P=N/A, N=267, Completed, Sponsor: National Taiwan University Hospital
Active, not recruiting --> Completed | N=259 --> 381 | Trial primary completion date: Jul 2018 --> Jan 2018 Recruiting --> Completed | N=160 --> 267
- | Erbitux (cetuximab) / Eli Lilly, EMD Serono
Trial primary completion date, Metastases: EAGLE: Neoadjuvant Erbitux Based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer (clinicaltrials.gov) - Aug 21, 2017
P2/3, N=243, Completed, Sponsor: Shanghai Jiao Tong University School of Medicine
Recruiting --> Completed | N=160 --> 267 Trial primary completion date: Dec 2016 --> Oct 2014
- | Enrollment closed, Enrollment change: Spectroscopy for Diagnostic Assessment of Oral Mucosal Lesions (clinicaltrials.gov) - Jul 28, 2017
P=N/A, N=259, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Trial primary completion date: Dec 2016 --> Oct 2014 Recruiting --> Active, not recruiting | N=395 --> 259
- | Enrollment change, Adherence: Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR (clinicaltrials.gov) - Jun 7, 2017
P=N/A, N=322, Completed, Sponsor: Michigan State University
Recruiting --> Active, not recruiting | N=395 --> 259 N=246 --> 322
- ||| Trial completion: Oromouth: HPV Prevalence in the Mouth and Oropharynx of the Tonsillectomy Population (clinicaltrials.gov) - May 18, 2017
P=N/A, N=937, Completed, Sponsor: University of Birmingham
N=246 --> 322 Recruiting --> Completed
- | Trial primary completion date: Acupuncture in Treating Dry Mouth Caused By Radiation Therapy in Patients With Head and Neck Cancer (clinicaltrials.gov) - May 16, 2017
P3, N=240, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Recruiting --> Completed Trial primary completion date: Nov 2017 --> Nov 2018
- | Enrollment change, Trial withdrawal: Diagnostic Aids for Detection and Diagnosis of Oral Cancer (clinicaltrials.gov) - Apr 27, 2017
P1, N=0, Withdrawn, Sponsor: M.D. Anderson Cancer Center
Trial primary completion date: Nov 2017 --> Nov 2018 N=500 --> 0 | Active, not recruiting --> Withdrawn
- | Trial completion: Neurocognitive Functioning in Patients With Newly Diagnosed Upper Aerodigestive Tract Cancer Receiving Treatment at Henry-Joyce Cancer Clinic (clinicaltrials.gov) - Apr 7, 2017
P=N/A, N=86, Completed, Sponsor: Vanderbilt University Medical Center
N=500 --> 0 | Active, not recruiting --> Withdrawn Active, not recruiting --> Completed
- Trial completion, Enrollment change: Polarized Reflectance Spectroscopy for Oral Lesions (clinicaltrials.gov) - Jan 31, 2017
P1, N=40, Completed, Sponsor: British Columbia Cancer Agency
Active, not recruiting --> Completed Recruiting --> Completed | N=150 --> 40
- Trial completion, Enrollment change: Natural History of Oro-pharyngeal Cancer Precursors (clinicaltrials.gov) - Jan 24, 2017
P=N/A, N=374, Completed, Sponsor: Albert Einstein College of Medicine of Yeshiva University
Recruiting --> Completed | N=150 --> 40 Withdrawn --> Completed | N=40 --> 374
- sirolimus / Generic mfg.
Trial primary completion date: Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma (clinicaltrials.gov) - Jan 19, 2017
P1/2, N=37, Completed, Sponsor: National Institute of Dental and Craniofacial Research (NIDCR)
Withdrawn --> Completed | N=40 --> 374 Trial primary completion date: Nov 2015 --> Jun 2015
- Enrollment open, Trial primary completion date: Spectroscopy for Diagnostic Assessment of Oral Mucosal Lesions (clinicaltrials.gov) - Jan 9, 2017
P=N/A, N=395, Recruiting, Sponsor: M.D. Anderson Cancer Center
Trial primary completion date: Nov 2015 --> Jun 2015 Active, not recruiting --> Recruiting | Trial primary completion date: Jul 2017 --> Jul 2018
- Trial completion, Enrollment change, Trial initiation date, Trial primary completion date: Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy (clinicaltrials.gov) - Sep 23, 2016
P=N/A, N=469, Completed, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Recruiting | Trial primary completion date: Jul 2017 --> Jul 2018 Active, not recruiting --> Completed | N=650 --> 469 | Initiation date: Jul 2005 --> Apr 2002 | Trial primary completion date: Nov 2017 --> Aug 2016
- Trial completion, Trial primary completion date, Adherence: Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR (clinicaltrials.gov) - Sep 20, 2016
P=N/A, N=246, Completed, Sponsor: Michigan State University
Active, not recruiting --> Completed | N=650 --> 469 | Initiation date: Jul 2005 --> Apr 2002 | Trial primary completion date: Nov 2017 --> Aug 2016 Recruiting --> Completed | Trial primary completion date: Feb 2017 --> Jul 2016
- | Trial completion: Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation Therapy (clinicaltrials.gov) - Jul 11, 2016
P3, N=18, Completed, Sponsor: Alliance for Clinical Trials in Oncology
Recruiting --> Completed | Trial primary completion date: Feb 2017 --> Jul 2016 No longer recruiting --> Completed
- Trial termination, Surgery, Biopsy: EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma (clinicaltrials.gov) - May 23, 2016
P1, N=0, Terminated, Sponsor: University Health Network, Toronto
No longer recruiting --> Completed Active, not recruiting --> Terminated; Lack of patient accrual
- Enrollment closed, Enrollment change: Fluorescent Visualization in Early Oral Cancer (clinicaltrials.gov) - May 18, 2016
P=N/A, N=40, Active, not recruiting, Sponsor: University of Calgary
Active, not recruiting --> Terminated; Lack of patient accrual Recruiting --> Active, not recruiting | N=60 --> 40
- ||| Trial completion, Enrollment change, Trial primary completion date: Efficacy of MUCIPLIQ on the Incidence of Radio-chemotherapy-induced Mucositis in Patients Suffering From Oral Cancer (clinicaltrials.gov) - May 5, 2016
P=N/A, N=136, Completed, Sponsor: Organ, Tissue, Regeneration, Repair and Replacement
Recruiting --> Active, not recruiting | N=60 --> 40 Recruiting --> Completed | N=105 --> 136 | Trial primary completion date: May 2015 --> Jan 2015
- Erbitux (cetuximab) / Eli Lilly, EMD Serono
Trial completion, Trial primary completion date, Metastases: A Study of Neoadjuvant Bio-C/T Followed by Concurrent Bio-R/T in High-risk Locally Advanced Oral Squamous Cell Carcinoma (clinicaltrials.gov) - May 4, 2016
P2, N=47, Completed, Sponsor: National Health Research Institutes, Taiwan
Recruiting --> Completed | N=105 --> 136 | Trial primary completion date: May 2015 --> Jan 2015 Recruiting --> Completed | Trial primary completion date: Mar 2011 --> Jul 2011
- Enrollment closed: Diagnostic Aids for Detection and Diagnosis of Oral Cancer (clinicaltrials.gov) - Apr 4, 2016
P1, N=500, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Recruiting --> Completed | Trial primary completion date: Mar 2011 --> Jul 2011 Recruiting --> Active, not recruiting
- Enrollment closed, Enrollment change, Trial primary completion date: Photodynamic Therapy in Treating Patients With Premalignant or Early Stage Head and Neck Tumors (clinicaltrials.gov) - Feb 10, 2016
P1, N=35, Active, not recruiting, Sponsor: Abramson Cancer Center of the University of Pennsylvania
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting | N=48 --> 35 | Trial primary completion date: Jul 2015 --> Oct 2014
- NN1213 / Novo Nordisk
Trial completion, Enrollment change, Surgery: Dentures and Dental Implants in Treating Patients Undergoing Surgery for Mouth Cancer (clinicaltrials.gov) - Feb 3, 2016
P2, N=46, Completed, Sponsor: Jonsson Comprehensive Cancer Center
Recruiting --> Active, not recruiting | N=48 --> 35 | Trial primary completion date: Jul 2015 --> Oct 2014 Active, not recruiting --> Completed | N=62 --> 46
- Trial primary completion date: Spectroscopy for Diagnostic Assessment of Oral Mucosal Lesions (clinicaltrials.gov) - Jan 17, 2016
P=N/A, N=395, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed | N=62 --> 46 Trial primary completion date: Jul 2016 --> Jul 2017
- | Enrollment closed, Trial primary completion date: Acupuncture in Treating Dry Mouth Caused By Radiation Therapy in Patients With Head and Neck Cancer (clinicaltrials.gov) - Dec 12, 2015
P3, N=240, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Trial primary completion date: Jul 2016 --> Jul 2017 Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2016 --> Nov 2017
- sirolimus / Generic mfg.
Trial completion, Trial primary completion date: Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma (clinicaltrials.gov) - Nov 15, 2015
P1/2, N=3, Completed, Sponsor: National Institute of Dental and Craniofacial Research (NIDCR)
Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2016 --> Nov 2017 Active, not recruiting --> Completed | Trial primary completion date: Jun 2016 --> Nov 2015
- albumin-bound paclitaxel / Generic mfg.
Biomarker, Enrollment change, Metastases: Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors (clinicaltrials.gov) - Oct 22, 2015
P=N/A, N=0, Withdrawn, Sponsor: Eastern Cooperative Oncology Group
Active, not recruiting --> Completed | Trial primary completion date: Jun 2016 --> Nov 2015 N=129 --> 0
- Trial completion: Zinc Supplements in Lowering Cadmium Levels in Smokers (clinicaltrials.gov) - Oct 3, 2015
P2, N=61, Completed, Sponsor: Comprehensive Cancer Center of Wake Forest University
N=129 --> 0 Active, not recruiting --> Completed
- Trial primary completion date: Polarized Reflectance Spectroscopy for Oral Lesions (clinicaltrials.gov) - Sep 24, 2015
P1, N=150, Recruiting, Sponsor: British Columbia Cancer Agency
Active, not recruiting --> Completed Trial primary completion date: Sep 2015 --> Dec 2015
- bupropion / Generic mfg.
Trial completion: Bupropion in Helping Adults Stop Smoking (clinicaltrials.gov) - Aug 28, 2015
P2, N=97, Completed, Sponsor: Roswell Park Cancer Institute
Trial primary completion date: Sep 2015 --> Dec 2015 Active, not recruiting --> Completed
- Trial completion: Trismus Trial of Therabite vs Wooden Spatula in Head and Neck Cancer Patients (clinicaltrials.gov) - Aug 14, 2015
P2, N=71, Completed, Sponsor: Colin Lunt
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion, Enrollment change: Clinical Evaluation of Bioadhesive Gels for Oral Cancer Chemoprevention (clinicaltrials.gov) - Aug 14, 2015
P1/2, N=41, Completed, Sponsor: Ohio State University
Active, not recruiting --> Completed Active, not recruiting --> Completed | N=72 --> 41
- Trial termination: Photodynamic Therapy Using HPPH in Treating Patients With Recurrent Dysplasia, Carcinoma in Situ, or Stage I Oral Cavity Cancer (clinicaltrials.gov) - Aug 14, 2015
P1, N=11, Terminated, Sponsor: Roswell Park Cancer Institute
Active, not recruiting --> Completed | N=72 --> 41 Active, not recruiting --> Terminated; safety issues
- Biomarker, Enrollment open, Trial primary completion date: Biomarkers in Tissue Samples From Patients Who Have Undergone Neck Dissection for Oral Cancer (clinicaltrials.gov) - Aug 12, 2015
P=N/A, N=161, Recruiting, Sponsor: Alliance for Clinical Trials in Oncology
Active, not recruiting --> Terminated; safety issues Active, not recruiting --> Recruiting | Trial primary completion date: Sep 2008 --> Jan 2100
- ||| Enrollment open, Enrollment change, Trial initiation date, Trial primary completion date: Oromouth: HPV Prevalence in the Mouth and Oropharynx of the Tonsillectomy Population (clinicaltrials.gov) - Jul 10, 2015
P=N/A, N=925, Recruiting, Sponsor: University of Birmingham
Active, not recruiting --> Recruiting | Trial primary completion date: Sep 2008 --> Jan 2100 Not yet recruiting --> Recruiting | N=1250 --> 925 | Initiation date: Aug 2011 --> Mar 2013 | Trial primary completion date: Jul 2014 --> Nov 2015
- Trial primary completion date: Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy (clinicaltrials.gov) - Jun 26, 2015
P=N/A, N=650, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Not yet recruiting --> Recruiting | N=1250 --> 925 | Initiation date: Aug 2011 --> Mar 2013 | Trial primary completion date: Jul 2014 --> Nov 2015 Trial primary completion date: Nov 2016 --> Nov 2017
- Enrollment change, Trial primary completion date: Photodynamic Therapy Using HPPH in Treating Patients With Recurrent Dysplasia, Carcinoma in Situ, or Stage I Oral Cavity Cancer (clinicaltrials.gov) - Jun 25, 2015
P1, N=11, Active, not recruiting, Sponsor: Roswell Park Cancer Institute
Trial primary completion date: Nov 2016 --> Nov 2017 N=30 --> 11 | Trial primary completion date: May 2015 --> Nov 2011
- Trial completion, Trial primary completion date: Epstein-Barr Detection in Oral Cancer (clinicaltrials.gov) - Jun 25, 2015
P=N/A, N=60, Completed, Sponsor: UPECLIN HC FM Botucatu Unesp
N=30 --> 11 | Trial primary completion date: May 2015 --> Nov 2011 Active, not recruiting --> Completed | Trial primary completion date: Nov 2009 --> Apr 2008
- || bupropion / Generic mfg.
Trial primary completion date: Bupropion in Helping Adults Stop Smoking (clinicaltrials.gov) - Jun 23, 2015
P2, N=97, Active, not recruiting, Sponsor: Roswell Park Cancer Institute
Active, not recruiting --> Completed | Trial primary completion date: Nov 2009 --> Apr 2008 Trial primary completion date: May 2009 --> May 2008
- || Trial primary completion date: Acceptability of Less Harmful Alternatives to Cigarettes (clinicaltrials.gov) - Jun 22, 2015
P=N/A, N=67, Completed, Sponsor: Roswell Park Cancer Institute
Trial primary completion date: May 2009 --> May 2008 Trial primary completion date: Nov 2009 --> Aug 2009
- sirolimus / Generic mfg.
Trial primary completion date: Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma (clinicaltrials.gov) - Jun 11, 2015
P1/2, N=3, Active, not recruiting, Sponsor: National Institute of Dental and Craniofacial Research (NIDCR)
Trial primary completion date: Nov 2009 --> Aug 2009 Trial primary completion date: Jun 2015 --> Jun 2016
- Enrollment change: Trismus Trial of Therabite vs Wooden Spatula in Head and Neck Cancer Patients (clinicaltrials.gov) - Jun 11, 2015
P2, N=71, Active, not recruiting, Sponsor: Colin Lunt
Trial primary completion date: Jun 2015 --> Jun 2016 N=112 --> 71
- Trial completion, Trial primary completion date: Web-based Education on Oral Cancer for Primary Care Physicians in Ohio (clinicaltrials.gov) - Mar 24, 2015
P=N/A, N=10, Completed, Sponsor: Creighton University
N=112 --> 71 Active, not recruiting --> Completed | Trial primary completion date: Feb 2013 --> Sep 2013
- Trial completion: A Study of the Effects of PEITC on Oral Cells With Mutant p53 (clinicaltrials.gov) - Mar 23, 2015
P1/2, N=55, Completed, Sponsor: Georgetown University
Active, not recruiting --> Completed | Trial primary completion date: Feb 2013 --> Sep 2013 Recruiting --> Completed